Board of Scientific Counselors, Office of Public Health Preparedness and Response (BSC, OPHPR), 20823 [2012-8290]

Download as PDF Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Public Health Preparedness and Response (BSC, OPHPR) mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 10:30 a.m.–6 p.m., May 1, 2012; 9 a.m.–3:45 p.m., May 2, 2012. Place: CDC, 1600 Clifton Road, NE., Roybal Campus, Atlanta, Georgia 30329. May 1, 2012: Building 19, Room 254/255. May 2, 2012: Building 21, Room 1204A/1204B. Status: Open to the public limited only by the space available. The meeting room will accommodate up to 75 people. Public participants should pre-register for the meeting as described in Additional Information for Public Participants. Purpose: This Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Office of Public Health Preparedness and Response (OPHPR), concerning strategies and goals for the programs and research within OPHPR, monitoring the overall strategic direction and focus of the OPHPR Divisions and Offices, and administration and oversight of peer review of OPHPR scientific programs. For additional information about the Board, please visit: https://www.cdc.gov/phpr/ science/counselors.htm. Matters To Be Discussed: Agenda items for this meeting include: (1) Briefings and BSC deliberation on the following topics: CDC Laboratory Preparedness; OPHPR Research Portfolio Budget; CDC’s Preparedness Index; Novel Approaches to Anti-Viral Delivery; CDC’s Anthrax Management Team; Estimating the Cost of Preparedness; (2) Programmatic responses to BSC-approved recommendations resulting from external peer review of: The Career Epidemiology Field Officer (CEFO) Program and the Preparedness and Emergency Response Research Centers (PERRCs) program; (3) BSC liaison representative updates to the Board highlighting organizational activities relevant to the OPHPR mission; (4) a discussion of a proposed ad hoc working group to review the Division of Strategic National Stockpile (DSNS). Agenda items are subject to change as priorities dictate. Additional Information for Public Participants: Members of the public that wish to attend this meeting should pre-register by submitting the following information by email, facsimile, or phone (see Contact Person for More Information) no later than 12:00 noon (EDT) on Monday, April 20, 2012: • Full Name, VerDate Mar<15>2010 16:17 Apr 05, 2012 Jkt 226001 • Organizational Affiliation, • Complete Mailing Address, • Citizenship, and • Phone Number or Email Address Contact Person for More Information: Carol Marsh, OPHPR BSC Coordinator, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop D–44, Atlanta, Georgia 30333, Telephone: (404) 639–4773; Facsimile: (404) 639–7977; Email: OPHPR.BSC.Questions@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: March 30, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–8290 Filed 4–5–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Prospective Grant of Exclusive License: Family Healthware Technology Transfer Office, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. ACTION: Notice. AGENCY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention (CDC), Technology Transfer Office, Department of Health and Human Services (DHHS), is contemplating the grant of a worldwide, exclusive license to practice the inventions embodied in the patent application referred to below to Sanitas Inc., having a place of business in La Jolla, California. The patent rights in these inventions have been assigned to the government of the United States of America. The patent application(s) to be licensed are: SUMMARY: US Patent Application 11/815,445 entitled ‘‘Personal Assessment Including Familial Risk Analysis for Personalized Disease Prevention Plan,’’ filed 5/20/2008, claiming priority to Provisional Patent Application No. 60/650,076, filed 2/3/2005. CDC Technology ID No. I–004–04. Status: Patent Application Pending. Priority Date: 2/3/2005. Issue Date: N/A. The prospective exclusive license will be royalty-bearing and will comply with PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 20823 the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. Technology: This technology provides a computer-based familial risk assessment tool. It involves a three-step process which uses the disease history of a person’s first and second-degree relatives to assess the risk of common diseases of adulthood in order to influence early disease detection and prevention strategies. ADDRESSES: Requests for a copy of this patent application, inquiries, comments, and other materials relating to the contemplated license should be directed to Donald Prather, J.D., Ph.D., Technology Licensing and Marketing Specialist, Technology Transfer Office, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway, Mailstop K–79, Atlanta, GA 30341, Telephone: (770) 488–8612; Facsimile: (770) 488–8615. Applications for a license filed in response to this notice will be treated as objections to the grant of the contemplated license. Only written comments and/or applications for a license which are received by CDC within thirty days of this notice will be considered. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: March 27, 2012. Tanja Popovic, Deputy Associate Director for Science Centers for Disease Control and Prevention. [FR Doc. 2012–8291 Filed 4–5–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0332] Jyotin Parikh: Debarment Order AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) debarring Jyotin Parikh for 5 years from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Mr. Parikh was convicted of one count of conspiracy to commit an offense against the United States for conduct relating to the SUMMARY: E:\FR\FM\06APN1.SGM 06APN1

Agencies

[Federal Register Volume 77, Number 67 (Friday, April 6, 2012)]
[Notices]
[Page 20823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8290]



[[Page 20823]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Public Health 
Preparedness and Response (BSC, OPHPR)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Times and Dates: 10:30 a.m.-6 p.m., May 1, 2012; 9 a.m.-3:45 
p.m., May 2, 2012.
    Place: CDC, 1600 Clifton Road, NE., Roybal Campus, Atlanta, 
Georgia 30329. May 1, 2012: Building 19, Room 254/255. May 2, 2012: 
Building 21, Room 1204A/1204B.
    Status: Open to the public limited only by the space available. 
The meeting room will accommodate up to 75 people. Public 
participants should pre-register for the meeting as described in 
Additional Information for Public Participants.
    Purpose: This Board is charged with providing advice and 
guidance to the Secretary, Department of Health and Human Services 
(HHS), the Assistant Secretary for Health (ASH), the Director, 
Centers for Disease Control and Prevention (CDC), and the Director, 
Office of Public Health Preparedness and Response (OPHPR), 
concerning strategies and goals for the programs and research within 
OPHPR, monitoring the overall strategic direction and focus of the 
OPHPR Divisions and Offices, and administration and oversight of 
peer review of OPHPR scientific programs. For additional information 
about the Board, please visit: https://www.cdc.gov/phpr/science/counselors.htm.
    Matters To Be Discussed: Agenda items for this meeting include: 
(1) Briefings and BSC deliberation on the following topics: CDC 
Laboratory Preparedness; OPHPR Research Portfolio Budget; CDC's 
Preparedness Index; Novel Approaches to Anti-Viral Delivery; CDC's 
Anthrax Management Team; Estimating the Cost of Preparedness; (2) 
Programmatic responses to BSC-approved recommendations resulting 
from external peer review of: The Career Epidemiology Field Officer 
(CEFO) Program and the Preparedness and Emergency Response Research 
Centers (PERRCs) program; (3) BSC liaison representative updates to 
the Board highlighting organizational activities relevant to the 
OPHPR mission; (4) a discussion of a proposed ad hoc working group 
to review the Division of Strategic National Stockpile (DSNS).
    Agenda items are subject to change as priorities dictate.
    Additional Information for Public Participants: Members of the 
public that wish to attend this meeting should pre-register by 
submitting the following information by email, facsimile, or phone 
(see Contact Person for More Information) no later than 12:00 noon 
(EDT) on Monday, April 20, 2012:
     Full Name,
     Organizational Affiliation,
     Complete Mailing Address,
     Citizenship, and
     Phone Number or Email Address
    Contact Person for More Information: Carol Marsh, OPHPR BSC 
Coordinator, Centers for Disease Control and Prevention, 1600 
Clifton Road, NE., Mailstop D-44, Atlanta, Georgia 30333, Telephone: 
(404) 639-4773; Facsimile: (404) 639-7977; Email: 
OPHPR.BSC.Questions@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 30, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-8290 Filed 4-5-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.